Consolidated Statements of Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Consolidated Statements of Loss
Revenue	$ 0	$ 1,000
Operating expenses
Research and development, net of tax credits	14,357	31,052
General and administrative	16,742	15,932
Commercial	11,003	15,114
Loss from operations	(42,102)	(61,098)
Interest income	4,164	3,967
Interest expense	(3,581)	(2,554)
Net loss and comprehensive loss	$ (41,519)	$ (59,685)
Weighted average number of shares and pre-funded warrants outstanding, basic (in shares)	62,210,702	42,955,779
Weighted average number of shares and pre-funded warrants outstanding, diluted (in shares)	62,210,702	42,955,779
Net loss per share, basic (in dollars per share)	$ (0.67)	$ (1.39)
Net loss per share, diluted (in dollars per share)	$ (0.67)	$ (1.39)